Sara Charleer (S Charleer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

Diabetes technology & therapeutics

Journal of endocrinological investigation

Diabetologia

Diabetes, obesity & metabolism

Fonds Wetenschappelijk Onderzoek

KU Leuven (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fonds Wetenschappelijk Onderzoek Jan 01 2017

Belgium

PhD fellowship strategic basic research

KU Leuven Aug 16 2016

Belgium

PhD researcher :: Clinical & Experimental Endocrinology

Education History

KU Leuven Sep 21 2014 - Jul 01 2016

Belgium

MSC :: Faculty of Medicine

KU Leuven Sep 20 2011 - Jul 01 2014

Belgium

BSC :: Faculty of Medicine

Publications

Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia (2024)
E Soubry, Karel David, Ann Swillen, Elfi Vergaelen, M Docx Op de Beeck, M Hulsmans, Sara Charleer, Brigitte Decallonne
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of endocrinological investigation 47 (7) (2024)
E Soubry, Karel David, Ann Swillen, Elfi Vergaelen, M Docx Op de Beeck, M Hulsmans, Sara Charleer, Brigitte Decallonne
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of endocrinological investigation 47 (7) (2024)
Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer, Anne Rochtus, Kristina Casteels
The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population. Diabetes technology & therapeutics 26 (5) (2024)
E Soubry, Karel David, Ann Swillen, Elfi Vergaelen, M Docx Op de Beeck, M Hulsmans, Sara Charleer, Brigitte Decallonne
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of endocrinological investigation (2024)
E Soubry, Karel David, Ann Swillen, Elfi Vergaelen, M Docx Op de Beeck, M Hulsmans, Sara Charleer, Brigitte Decallonne
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of endocrinological investigation 47 (7) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics 26 (7) (2024)
E Soubry, Karel David, Ann Swillen, Elfi Vergaelen, M Docx Op de Beeck, M Hulsmans, Sara Charleer, Brigitte Decallonne
Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study. Journal of endocrinological investigation 47 (7) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics (2024)
Robbe De Groote, Eveline Lefever, Sara Charleer, Phebe Donné, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins. Diabetes technology & therapeutics (2024)
Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia 67 (8) (2024)
Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer, Anne Rochtus, Kristina Casteels
The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population. Diabetes technology & therapeutics 26 (5) (2024)
Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia 67 (8) (2024)
Robbe De Groote, Eveline Lefever, Sara Charleer, Phebe Donné, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins. Diabetes technology & therapeutics 26 (8) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics 26 (7) (2024)
Mathilde Vandenbempt, Hanne Matheussen, Sara Charleer, Anne Rochtus, Kristina Casteels
The Relationship Between Glycated Hemoglobin and Time in Range in a Pediatric Population. Diabetes technology & therapeutics (2024)
Sara Charleer, Christophe E M De Block, Nancy Bolsens, Liesbeth Van Huffel, Frank Nobels, Chantal Mathieu, Pieter Gillard
Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia. Diabetes technology & therapeutics (2023)
Laura M Jacobsen, Jennifer L Sherr, Elizabeth G Considine, Angela Chen, Sarah M Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, Selma Alamarie, Maria J Redondo, Korey K Hood, Peter A Gottlieb, Pieter Gillard, Jessie J Wong, Irl B Hirsch, Richard E Pratley, Lori M Laffel, Chantal Mathieu, null null
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Communications medicine 3 (1) (2023)
Margaretha Martha Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, Chris Vercammen, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Pieter Gillard
The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Journal of diabetes science and technology (2022)
Ben Broos, Sara Charleer, Nancy Bolsens, Carolien Moyson, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK. The Journal of clinical endocrinology and metabolism 106 (8) (2021)
Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx, Kato Vangelabbeek, Nathalie De Block, Charlien Janssen, Kristof Van Dessel, Eveline Lia Dirinck, Frida Peiffer, Nancy Bolsens, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring. Diabetes, obesity & metabolism 23 (12) (2021)
Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Lia Dirinck, Kristien J Ledeganck, Bart Keymeulen, Laurent Crenier, Régis Pierre Radermecker, Youri Taes, Chris Vercammen, Frank Nobels, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus. The Journal of clinical endocrinology and metabolism (2021)
Sara Charleer, Christophe De Block, Frank Nobels, Régis P Radermecker, Ine Lowyck, Annelies Mullens, Denis Scarnière, Katrien Spincemaille, Marie Strivay, Eric Weber, Youri Taes, Chris Vercammen, Bart Keymeulen, Chantal Mathieu, Pieter Gillard, null null
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes care 43 (12) (2020)
Sara Charleer, Pieter Gillard, Eva Vandoorne, Kelly Cammaerts, Chantal Mathieu, Kristina Casteels
Intermittently scanned continuous glucose monitoring is associated with high satisfaction but increased HbA1c and weight in well-controlled youth with type 1 diabetes. Pediatric diabetes 21 (8) (2020)
Sara Charleer, Christophe E M De Block, Liesbeth Van Huffel, Ben Broos, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes care 43 (2) (2019)
Sara Charleer, Chantal Mathieu, Frank Nobels, Pieter Gillard
Accuracy and precision of flash glucose monitoring sensors inserted into the abdomen and upper thigh compared with the upper arm. Diabetes, obesity & metabolism 20 (6) (2018)

Sara Charleer.css-eqlu8i{font-size:small;padding-left:4px;} (S Charleer)

Publication Activity (10 Years)

Top Topics

Top Venues

Sara Charleer (S Charleer)